4//SEC Filing
Mullennix Stephen 4
Accession 0001209191-19-056923
CIK 0001668243other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:04 PM ET
Size
8.9 KB
Accession
0001209191-19-056923
Insider Transaction Report
Form 4
Mullennix Stephen
Chief Operating Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2019-11-14+1,759→ 8,291 total - Exercise/Conversion
Restricted Stock Units
2019-11-14−1,759→ 8,796 total→ Ordinary Shares (1,759 underlying) - Sale
Ordinary Shares
2019-11-14$26.00/sh−608$15,806→ 7,683 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001764139
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:04 PM ET
- Size
- 8.9 KB